Table 1.
Basic demographics and clinical information for the recruited patients.
| Middle Age (40–59 years) |
Old Age (60–79 years) |
Very Old (80–100 years) |
P-values* | P-values Old vs Very Old | |
|---|---|---|---|---|---|
| n = 23 | n = 50 | n = 30 | |||
| Male, n % | 6 (26) | 35 (70) | 14 (47) | 0.003 | 0.039 |
| Body Mass Index, kb/m2 | 35 ± 6 | 30 ± 5 | 28 ± 5 | 0.713 | 0.789 |
| PLT Count (x 103per μl) | 233 ± 27 | 214 ± 81 | 210 ± 72 | 0.925 | 0.973 |
| HbA1c (%) | 5.9 ± 0.4 | 7.0 ± 2.0 | 6.7 ± 1.7 | 0.941 | 0.917 |
| BSL (mg/dl) | 109 ± 17 | 136 ± 63 | 119 ± 33 | 0.003 | 0.839 |
| Diabetes, n (%) | 4 (17.4) | 22 (44.0) | 9 (30) | 0.071 | 0.243 |
| Hypertension, n (%) | 14 (60.8) | 43 (86.0) | 28 (93.3) | 0.006 | 0.315 |
| Hyperlipidemia, n (%) | 9 (39.1) | 30 (60.0) | 21 (70) | 0.073 | 0.368 |
| Current Smoker, n (%) | 3 (13.0) | 9 (18.0) | 2 (6.66) | 0.3573 | 0.154 |
| Documented CAD, n (%) | 4 (17.3) | 30 (60.0) | 15 (50) | 0.003 | 0.383 |
| Aspirin use, n (%) | 10 (43.4) | 36 (72.0) | 21 (70) | 0.06 | 0.999 |
| Statin use, n (%) | 13 (56.5) | 41 (82.0) | 27 (90) | 0.009 | 0.332 |
| β-blocker use, n (%) | 17 (73.9) | 39 (78.0) | 25 (83.3) | 0.701 | 0.564 |
| Diuretics use, n (%) | 12 (52.2) | 22 (44.0) | 16 (53.3) | 0.182 | 0.459 |
| Cancer diagnosis, n (%) | 0 (0) | 6 (12.0) | 2 (6.66) | 0.198 | 0.441 |